Sources | Names Used |
---|---|
CTRPv2 | compound 1B |
PharmacoGx | compound 1B |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IFNGR1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
mRNA | ST6GALNAC6 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
mRNA | SLC25A53 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
mRNA | RP11-12J10.3 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
mRNA | FBLN1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
mRNA | ATG101 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
mRNA | ARIH2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
mRNA | SRPRB | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
mRNA | UBE3A | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
mRNA | CPT1C | CTRPv2 | pan-cancer | AAC | -0.086 | 0.06 |